Nasilin, Baby Boy .

HRN: 28-52-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2026
AMPICILLIN 250MG (VIAL)
02/06/2026
02/13/2026
IVTT
145mg
Q12h
PSNB
Remove - Pending Acceptance
02/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/06/2026
02/13/2026
IVTT
45mg
Q24h
PSNB
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: